[G protein-coupled estrogen receptor alleviates cerebral ischemia-reperfusion injury through inhibiting endoplasmic reticulum stress]. 2019

Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
Department of Physiology, Shihezi University Medical College/Xinjiang Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Shihezi 832002, China.

The aim of this study was to investigate whether G protein-coupled estrogen receptor (GPER) could alleviate hippocampal neuron injury under cerebral ischemia-reperfusion injury (CIRI) by acting on endoplasmic reticulum stress (ERS). The CIRI animal model was established by middle cerebral artery occlusion (MCAO). Female ovariectomized (OVX) Sprague-Dawley (SD) female rats were randomly divided into 4 groups: control, ischemia-reperfusion injury (MCAO), vehicle (MCAO+DMSO), and GPER-specific agonist G1 (MCAO+G1) groups. The neurobehavioral score was assessed by the Longa score method, the morphological changes of the neurons were observed by the Nissl staining, the cerebral infarction was detected by the TTC staining, and the neural apoptosis in the hippocampal CA1 region was detected by TUNEL staining. The distribution and expression of GRP78 (78 kDa glucose-regulated protein 78) in the hippocampal CA1 region were observed by immunofluorescent staining. The protein expression levels of GRP78, Caspase-12, CHOP and Caspase-3 were detected by Western blot, and the mRNA expression levels of GRP78, Caspase-12, and CHOP were detected by the real-time PCR. The results showed that the neurobehavioral score, cerebral infarct volume, cellular apoptosis index, as well as GRP78, Caspase-12 and CHOP protein and mRNA expression levels in the MCAO group were significantly higher than those of control group. And G1 reversed the above-mentioned changes in the MCAO+G1 group. These results suggest that the activation of GPER can decrease the apoptosis of hippocampal neurons and relieve CIRI, and its mechanism may involve the inhibition of ERS.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D005260 Female Females
D006360 Heat-Shock Proteins Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions. Stress Protein,Stress Proteins,Heat-Shock Protein,Heat Shock Protein,Heat Shock Proteins,Protein, Stress
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
April 2021, Molecular medicine reports,
Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
April 2023, Cardiovascular drugs and therapy,
Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
January 2022, PPAR research,
Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
December 2018, Brain research,
Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
January 2021, Translational neuroscience,
Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
May 2021, Journal of cellular physiology,
Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
January 2022, International immunopharmacology,
Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
May 2022, Neurochemical research,
Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
February 2024, Heliyon,
Zi-Wei Han, and Li-Cang Zhu, and Yue-Chen Chang, and Ying Zhou, and Jia-An Zong, and Ke-Tao Ma, and Jun-Qiang Si, and Li Li
October 2021, European journal of pharmacology,
Copied contents to your clipboard!